Business Wire

BYD

27.2.2024 16:21:34 CET | Business Wire | Press release

Share
BYD Shortlisted in the Top Three for the 2024 World Car Awards

At the Geneva Motor Show on February 26, the World Car Awards announced the top three finalists for 2024. BYD's models, the BYD SEAL and the BYD DOLPHIN, excelled among a host of competitors, securing spots in the top three for the "World Car of the Year" and "World Urban Car" categories, respectively, and progressing to the final round of the competition. BYD makes history as the first and only Chinese carmaker to be shortlisted in the top three for the "World Car of the Year" category.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240227393340/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

BYD SEAL shortlisted in the Top 3 for the "World Car of the Year" category (Photo: Business Wire)

Regarded as the top three automotive accolades globally, the "World Car Awards," "European Car of the Year," and "North American Car of the Year" are highly esteemed. Dubbed the "Oscars of the automotive world", the "World Car Awards" is particularly celebrated for its emphasis on international models, positioning it as a highly anticipated event within the global automotive industry. BYD's exceptional performance highlights its status as a global leader in the New Energy Vehicle space.

These two models, with their distinctive design, cutting-edge technology, and robust safety features, captured the interest of over 100 automotive media experts from 29 countries. In 2023, the BYD SEAL and BYD DOLPHIN achieved five-star ratings in Euro NCAP and ANCAP tests. Notably, BYD SEAL was also nominated for the final European Car of the Year 2024.

As a frontrunner in the new energy vehicle sector, BYD achieved a milestone with over 3 million new energy vehicle sales in 2023, securing the top spot in global sales, for the second year in a row and breaking into the top ten global automotive brands — a first for a Chinese automaker.

So far, BYD's new energy vehicles have a substantial presence across over 70 countries and regions on six continents, encompassing more than 400 cities. In 2023, BYD emerged as a frontrunner in new energy vehicle sales across various international markets, including Thailand, Singapore, Colombia, and Brazil, garnering extensive consumer acclaim and preference.

Aligning with the World Car Awards' mission to foster continual innovation in the automotive sector, BYD is committed to building a comprehensive zero-emission new energy solution through technological innovations. It aims to enhance consumer travel experiences, spearhead the new energy vehicle industry's growth, and actively contribute to the automotive industry's transformation and progress. Looking ahead, BYD will steadfastly pursue its vision to "Cool the Earth by 1°C," continually driving the industry's green and low-carbon transformation and global sustainable development.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240227393340/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain15.9.2026 13:30:00 CEST | Press release

- Vonn shares her experience using JOURNAVX to manage her acute pain after a career-altering injury at the 2026 Winter Games - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX® (suzetrigine), a prescription non-opioid medicine for the treatment of moderate-to-severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in January 2025, JOURNAVX marked the first new class of pain medicine in over 20 years — since then JOURNAVX has been prescribed to over one million Americans. During the 2026 Winter Games in Milano Cortina, Lindsey suffered a serious crash during her downhill race. The fall resulted in multiple injuries that required immediate surgery and several additional procedures. Now, Lindsey is sharing her story and her personal experience treating her moderate-to-severe acute pain with JOURNAVX. “I have experienced countless injuries thro

Kinaxis Advances Operational Orchestration Vision with Agentic AI at Kinexions EMEA 202615.9.2026 13:00:00 CEST | Press release

Global brands including Bosch, Castrol, Coca-Cola Al Ahlia Beverages, and Moët Hennessy take the stage in Barcelona as Kinaxis sets the direction for the next era of supply chain Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, will bring together some of the world’s most innovative supply chain leaders at Kinexions EMEA 2026 from October 26-28. Building on the operational orchestration vision Kinaxis introduced earlier this year, the conference offers an inside look at how leading organizations are harnessing AI innovation and agentic capabilities to help supply chain leaders make better decisions, coordinate action across the business and drive measurable outcomes. From AI Potential to Operational Impact As organizations continue to invest heavily in AI, many struggle to translate intelligence into action - just 12% of supply chain leaders consider themselves AI leaders, despite widespread deployment of AI capabilities. Kinaxis CEO Razat

Cebreo Medical Receives CE Mark for NeuroBuds®, a Discreet In-Ear, Medical-Grade EEG Wearable for Extended Ambulatory Monitoring15.9.2026 13:00:00 CEST | Press release

The Danish medtech company's ear-EEG platform can now be placed on the European market, enabling clinicians to record multi-day and multi-night EEG in the patient's home for epilepsy, sleep and other neurophysiological research and care. Cebreo Medical today announced that its NeuroBuds® device has received CE marking, confirming conformity with applicable EU requirements. Unlike conventional EEG systems that require a technician-applied cap of electrodes, NeuroBuds is designed to be used unassisted by the patient at home, enabling multi-day and multi-night recordings in a patient's daily life environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914704547/en/ NeuroBuds(TM), EarEEG “With NeuroBuds, we can offer a discreet, unobtrusive solution that enables long-term, unassisted EEG monitoring for weeks, in patients’ own homes. The product has the potential to significantly reduce the cost of long-term EEG monitoring

Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 12:30:00 CEST | Press release

New U.S. healthcare provider (HCP) disease education initiative, Change the Tunein TRD explores the neurobiology and care pathways to support greater recognition and understanding of treatment-resistant depression (TRD)​ TRD occurs when people with major depressive disorder (MDD) are failed by at least two different antidepressant treatment regimens of adequate dose, duration and adherence in the same episode Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated

NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 12:00:00 CEST | Press release

Building on NIQ's GeoPurchase capabilities, the new solution extends geographic purchase intelligence into digital-first categories across Europe NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these sig

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye